New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies Variational AI, the company behind Enki, an advanced foundation model for small molecule ...

Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5 ...

“The Variational AI scientific team has spent years quietly building a foundation model constrained to small molecule drug discovery that uses orders of magnitude less compute and data than ...

We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team. VANCOUVER, British Columbia — Variational AI, the company behind Enki™, an ...

I’m incredibly proud of our teams and the milestone we have achieved, not only by showing the rich structure of the game world that a model like Muse can learn, as you see in the video demo below, but ...

The asymmetric KBTBD4 dimer assembly and unexpected dual-glue mechanism are reminders that emerging molecular-glue mechanisms are almost certain to include departures from the current model.

Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics (PDMB), MRL, Merck & Co., Inc., West Point, Pennsylvania 19486, United States ...

The new Model Y is almost here. Lower-priced variants aren’t far behind. Keep your eye on the price. The new Model Y base Dual-Motor and Rear-Wheel Drive versions will be considerably less ...